NR ATRV
AU Kim,N.H.; Choi,J.K.; Jeong,B.H.; Kim,J.I.; Kwon,M.S.; Carp,R.I.; Kim,Y.S.
TI Effect of transition metals (Mn, Cu, Fe) and deoxycholic acid (DA) on the conversion of PrPc to PrPres
QU The FASEB Journal 2005 May; 19(7): 783-5
PT journal article
AB The PMCA (protein misfolding cyclic amplification) technique has been shown to drive the amplification of misfolded prion protein by PrPsc seeds during several cycles of incubation-sonication. Here, we report that cyclic amplification of normal hamster brain homogenates treated with a number of transition metals (manganese [Mn], copper [Cu], and iron [Fe]) leads to conversion of PrPc into protease-resistant PrPres. The efficiency of PrPres formation and the glycoforms induced by Mn were different from those obtained by Cu and Fe. Previous results have shown higher Mn and lower Cu levels in the affinity-purified PrPsc from the brain of prion diseases compared with normal hamster brain homogenates. We focused on Mn because we observed higher levels of Mn in whole brain, mitochondria, and scrapie-associated fibril-enriched fractions from the brains of animals with prion disease. In the presence of minute quantities of Mn-induced PrPres template with a large amount of PrPc, PrPres amplification is observed. A metal chelater, EDTA reverses the effect of Mn on PrPres amplification, suggesting that Mn may play a role in the formation of PrPres. It has been proposed that metal-catalyzed oxidation of PrP leads to the oxidation of amino acids and extensive aggregation of oxidized PrP. Carboxyl acids such as deoxycholic acid (DA) are oxidized molecules produced by 3' oxidation pathway. In in vitro studies, the potent effect of Mn on PrPres amplification is augmented by DA in a dose-dependent manner. On the basis of the evidence of the elevated Mn levels in scrapie-associated fibril (SAF)-enriched preparations from the brains of animals with prion disease, Mn-loaded PrP and oxidized molecules such as carboxyl acids may contribute to the formation of the scrapie isoform of PrP in prion diseases.
MH Animals; Brain/drug effects/*metabolism; Brain Chemistry; Chelating Agents/pharmacology; Copper/pharmacology; Cricetinae; Deoxycholic Acid/*pharmacology; Edetic Acid/pharmacology; Endopeptidase K/pharmacology; Iron/pharmacology; Male; Manganese/analysis/pharmacology; Mesocricetus; Mice; Mice, Inbred C57BL; Oxidation-Reduction; Peptide Hydrolases/*metabolism; Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase/pharmacology; Prions/chemistry/*metabolism; Protein Folding; Research Support, Non-U.S. Gov't; Scrapie/metabolism; Transition Elements/*pharmacology
AD Ilsong Institute of Life Science, Anyang, Kyounggi-do, South Korea.
SP englisch
PO USA